Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational stu... von Jarvis, Helen, Craig, Dawn, Barker, Robert, Spiers, Gemma, Stow, Daniel, Anstee, Quentin M., Hanratty, Barbara

Volltext

From NASH to HCC: current concepts and future challenges von Anstee, Quentin M., Reeves, Helen L., Kotsiliti, Elena, Govaere, Olivier, Heikenwalder, Mathias

Volltext

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention von Younossi, Zobair, Anstee, Quentin M., Marietti, Milena, Hardy, Timothy, Henry, Linda, Eslam, Mohammed, George, Jacob, Bugianesi, Elisabetta

Volltext

Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum von Hardy, Timothy, Oakley, Fiona, Anstee, Quentin M, Day, Christopher P

Volltext

The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease von Boyle, Marie, Masson, Steven, Anstee, Quentin M.

Volltext

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management von McPherson, Stuart, Hardy, Tim, Henderson, Elsbeth, Burt, Alastair D, Day, Christopher P, Anstee, Quentin M

Volltext

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review von Lee, Jenny, Vali, Yasaman, Boursier, Jerome, Spijker, Rene, Anstee, Quentin M., Bossuyt, Patrick M., Zafarmand, Mohammad H.

Volltext

Current therapies and new developments in NASH von Dufour, Jean-François, Anstee, Quentin M, Bugianesi, Elisabetta, Harrison, Stephen, Loomba, Rohit, Paradis, Valerie, Tilg, Herbert, Wong, Vincent Wai-Sun, Zelber-sagi, Shira

Volltext

Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis von Lee, Jenny, Vali, Yasaman, Boursier, Jerome, Duffin, Kevin, Verheij, Joanne, Brosnan, M. Julia, Zwinderman, Koos, Anstee, Quentin M., Bossuyt, Patrick M., Zafarmand, Mohammad Hadi

Volltext

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH von Francque, Sven M, Bedossa, Pierre, Ratziu, Vlad, Anstee, Quentin M, Bugianesi, Elisabetta, Sanyal, Arun J, Loomba, Rohit, Harrison, Stephen A, Balabanska, Rozalina, Mateva, Lyudmila, Lanthier, Nicolas, Alkhouri, Naim, Moreno, Christophe, Schattenberg, Jörn M, Stefanova-Petrova, Diana, Vonghia, Luisa, Rouzier, Régine, Guillaume, Maeva, Hodge, Alexander, Romero-Gómez, Manuel, Huot-Marchand, Philippe, Baudin, Martine, Richard, Marie-Paule, Abitbol, Jean-Louis, Broqua, Pierre, Junien, Jean-Louis, Abdelmalek, Manal F

Volltext

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 von Estes, Chris, Anstee, Quentin M., Arias-Loste, Maria Teresa, Bantel, Heike, Bellentani, Stefano, Caballeria, Joan, Colombo, Massimo, Craxi, Antonio, Crespo, Javier, Day, Christopher P., Eguchi, Yuichiro, Geier, Andreas, Kondili, Loreta A., Kroy, Daniela C., Lazarus, Jeffrey V., Loomba, Rohit, Manns, Michael P., Marchesini, Giulio, Nakajima, Atsushi, Negro, Francesco, Petta, Salvatore, Ratziu, Vlad, Romero-Gomez, Manuel, Sanyal, Arun, Schattenberg, Jörn M., Tacke, Frank, Tanaka, Junko, Trautwein, Christian, Wei, Lai, Zeuzem, Stefan, Razavi, Homie

Volltext

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests von Masoodi, Mojgan, Gastaldelli, Amalia, Hyötyläinen, Tuulia, Arretxe, Enara, Alonso, Cristina, Gaggini, Melania, Brosnan, Julia, Anstee, Quentin M., Millet, Oscar, Ortiz, Pablo, Mato, Jose M., Dufour, Jean-Francois, Orešič, Matej

Volltext

Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis von Krenkel, Oliver, Puengel, Tobias, Govaere, Olivier, Abdallah, Ali T., Mossanen, Jana C., Kohlhepp, Marlene, Liepelt, Anke, Lefebvre, Eric, Luedde, Tom, Hellerbrand, Claus, Weiskirchen, Ralf, Longerich, Thomas, Costa, Ivan G., Anstee, Quentin M., Trautwein, Christian, Tacke, Frank

Volltext

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores von Bianco, Cristiana, Jamialahmadi, Oveis, Pelusi, Serena, Baselli, Guido, Dongiovanni, Paola, Zanoni, Irene, Santoro, Luigi, Maier, Silvia, Liguori, Antonio, Meroni, Marica, Borroni, Vittorio, D’Ambrosio, Roberta, Spagnuolo, Rocco, Alisi, Anna, Federico, Alessandro, Bugianesi, Elisabetta, Petta, Salvatore, Miele, Luca, Vespasiani-Gentilucci, Umberto, Anstee, Quentin M., Stickel, Felix, Hampe, Jochen, Fischer, Janett, Berg, Thomas, Fracanzani, Anna Ludovica, Soardo, Giorgio, Reeves, Helen, Prati, Daniele, Romeo, Stefano, Valenti, Luca

Volltext

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease von Hardy, Timothy, Zeybel, Mujdat, Day, Christopher P, Dipper, Christian, Masson, Steven, McPherson, Stuart, Henderson, Elsbeth, Tiniakos, Dina, White, Steve, French, Jeremy, Mann, Derek A, Anstee, Quentin M, Mann, Jelena

Volltext

Cellular senescence drives age-dependent hepatic steatosis von Ogrodnik, Mikolaj, Miwa, Satomi, Tchkonia, Tamar, Tiniakos, Dina, Wilson, Caroline L., Lahat, Albert, Day, Christoper P., Burt, Alastair, Palmer, Allyson, Anstee, Quentin M., Grellscheid, Sushma Nagaraja, Hoeijmakers, Jan H J., Barnhoorn, Sander, Mann, Derek A., Bird, Thomas G., Vermeij, Wilbert P., Kirkland, James L., Passos, João F., von Zglinicki, Thomas, Jurk, Diana

Volltext

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity von Shalapour, Shabnam, Lin, Xue-Jia, Bastian, Ingmar N., Brain, John, Burt, Alastair D., Aksenov, Alexander A., Vrbanac, Alison F., Li, Weihua, Perkins, Andres, Matsutani, Takaji, Zhong, Zhenyu, Dhar, Debanjan, Navas-Molina, Jose A., Xu, Jun, Loomba, Rohit, Downes, Michael, Yu, Ruth T., Evans, Ronald M., Dorrestein, Pieter C., Knight, Rob, Benner, Christopher, Anstee, Quentin M., Karin, Michael

Volltext

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis von Younossi, Zobair M., Loomba, Rohit, Anstee, Quentin M., Rinella, Mary E., Bugianesi, Elisabetta, Marchesini, Giulio, Neuschwander‐Tetri, Brent A., Serfaty, Lawrence, Negro, Francesco, Caldwell, Stephen H., Ratziu, Vlad, Corey, Kathleen E., Friedman, Scott L., Abdelmalek, Manal F., Harrison, Stephen A., Sanyal, Arun J., Lavine, Joel E., Mathurin, Philippe, Charlton, Michael R., Goodman, Zachary D., Chalasani, Naga P., Kowdley, Kris V., George, Jacob, Lindor, Keith

Volltext

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials von Anstee, Quentin M., Lawitz, Eric J., Alkhouri, Naim, Wong, Vincent Wai‐Sun, Romero‐Gomez, Manuel, Okanoue, Takeshi, Trauner, Michael, Kersey, Kathryn, Li, Georgia, Han, Ling, Jia, Catherine, Wang, Lulu, Chen, Guang, Subramanian, G. Mani, Myers, Robert P., Djedjos, C. Stephen, Kohli, Anita, Bzowej, Natalie, Younes, Ziad, Sarin, Shiv, Shiffman, Mitchell L., Harrison, Stephen A., Afdhal, Nezam H., Goodman, Zachary, Younossi, Zobair M.

Volltext

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis von Younossi, Zobair M., Loomba, Rohit, Rinella, Mary E., Bugianesi, Elisabetta, Marchesini, Giulio, Neuschwander‐Tetri, Brent A., Serfaty, Lawrence, Negro, Francesco, Caldwell, Stephen H., Ratziu, Vlad, Corey, Kathleen E., Friedman, Scott L., Abdelmalek, Manal F., Harrison, Stephen A., Sanyal, Arun J., Lavine, Joel E., Mathurin, Philippe, Charlton, Michael R., Chalasani, Naga P., Anstee, Quentin M., Kowdley, Kris V., George, Jacob, Goodman, Zachary D., Lindor, Keith

Volltext